i
IBB
iShares Biotechnology ETF
174.98
4.94+2.91%After Hours: 174.20 -0.78 -0.45%18:51 02/06 EST
OPEN/PREV CLOSE171.79/170.04
TODAY RANGE171.17-175.16
VOL2.49M
TOTAL ASSET8.54B
52 WEEK RANGE107.25-179.64
% TURNOVER0%
NAV174.93
EXPENSE RATIO(NET)0.44%
1Y RETURN(CUM.)24.80%
DIVIDEND0.3871
DIV YIELD0.22%
EX-DATE12/16/2025
% RANGE2.35%
INCEPTION DATE02/05/2001
BETA--
LOT SIZE1
LIPPER RATING★★☆☆☆
News
Seeking Alpha·1d ago
Revenge Of The Dividend Stocks
Benzinga·3d ago
Amcor, Emerson Electric And More: CNBC's 'Final Trades'
Seeking Alpha·01/29 14:00
Pfizer: A High-Yield Pharma At A Turning Point
Seeking Alpha·01/29 04:50
The Diversification Role Mid-Cap Stocks Can Play
Seeking Alpha·01/27 10:10
IBB: Beyond The 2025 Surge, Biotech Breakout
Seeking Alpha·01/26 11:22
IBB: Biotech's Hot Streak May Cool
Seeking Alpha·01/22 18:04
Healthcare debate should focus on out-of-pocket costs, not list prices – Novartis CEO
Seeking Alpha·01/22 11:07
Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?
Benzinga·01/14 17:23
Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground
Seeking Alpha·01/13 11:30
U.S. Earnings: Broadening Strength
NASDAQ·01/09 15:00
Here's Why Biotech ETFs Are Rallying Hard
Seeking Alpha·01/08 18:15
Biopharma stocks to see increased M&A activity amid Eli Lilly-Ventyx deal
Seeking Alpha·01/08 10:30
Healthcare Stocks In Focus: Assessing The Outlook For 2026
Benzinga·01/06 18:09
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others